Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer

Breakthrough In Lung Cancer Treatment, Study Finds

zeenews.india.com - 01/Jul 01:08

Patients had numerically better but statistically similar five-year overall survival rates for IMRT (30.8 per cent) compared to 3D-CRT (26.6 per...

Roche provides update on phase II/III SKYSCRAPER-06 study in metastatic non-squamous non-small cell lung cancer

drugs.com - 05/Jul 00:07

Basel, 04 July 2024 - Roche announced today that the phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq (atezolizumab) and...

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

drugs.com - 02/Jul 15:07

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be...

Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of patients

oncologynews.com.au - 25/Jun 12:37

An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...

Survival Improves With Open Hysterectomy for Cervical Cancer

drugs.com - 28/Jun 15:03

FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally...

Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

zacks.com - 24/Jun 18:10

Bristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted treatment option for adult patients with...

New global research aims to improve survival rates for pancreatic cancer patients

oncologynews.com.au - 26/Jun 15:44

A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...

PD-1 Non-Small Cell Lung Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:16

DelveInsight’s, “PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) Pipeline Insight 2024” report provides comprehensive...

Mediterranean Diet Ups Survival Odds After Cancer

drugs.com - 03/Jul 12:07

WEDNESDAY, July 3, 2024 -- The Mediterranean diet can help cancer survivors maintain their heart health and live longer, a new study says. Cancer...

Genentech Provides Update on Phase II/III Skyscraper-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer

drugs.com - 03/Jul 06:07

South San Francisco, CA -- July 3, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III...

Rubriques :